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Heart failure: unfavorable patient prognosis  
from the coexistence of many diseases
Niewydolność serca — niekorzystne rokowanie u pacjenta  
ze współistnieniem wielu chorób
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Abstract
Due to its incidence (approx. 750,000 patients in Poland) and simultaneous short survival time (only approx. 50% of 
patients survive 4 years after the diagnosis), heart failure (HF) poses a serious problem in contemporary cardiology. 
The clinical case presented below concerns a HF patient with multiple comorbidities which make prognosis significantly 
more difficult. Clinical assessment is of key importance with regard to the determination of treatment and the decision 
to implement palliative care. Despite the administration of optimal pharmacological treatment of HF, the condition of 
the patient in question deteriorated significantly within two months — to such extent that treatment characteristic of 
the end-of-life period had to be implemented. Such procedure is supported by the current scientific reports suggesting 
the implementation of palliative treatment already at earlier stages of HF advancement, particularly in patients with 
severe comorbidities.
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Introduction
Heart failure (HF) is a condition consisting in reduced sup-
ply of oxygenated blood to body tissues in relation to their 
metabolic needs. It stems from abnormal function of the 
myocardium and manifests primarily by reduced tolerance 
to effort, dyspnea and peripheral edema. Due to its high 
incidence in the population and short average survival time 
from the moment of diagnosis (only 50% of patients survive 
4 years after the diagnosis), HF poses a serious problem in 
contemporary cardiology. It is estimated that approximately 
750,000 people are suffering from heart failure in Poland 
[1]. In this article we are presenting a number of diagnostic 
and treatment-related difficulties encountered by physi-
cians caring for HF patients with multiple comorbidities. 
In such case, consideration should be given to prognosis 
evaluation and making of a possible decision regarding 
withdrawal of futile medical care and implementation of 
palliative care [2].
Case study
A 78-year-old patient with obesity, type 2 diabetes, asthma 
and left His bundle branch block was admitted to the Clinic 
of Cardiology due to increasing dyspnea and worsening 
tolerance to physical effort. At admission, the patient was 
in a serious condition, suffering from resting dyspnea. Au-
sculatory examination revealed reduced vesicular murmur 
above the lung fields and rales below scapular angles. 
Moderate peripheral edemas and bradychardia [heart rate 
313www.journals.viamedica.pl/folia_cardiologica
Tomasz Adam Michalski et al., HF: unfavorable patient prognosis from the coexistence of many diseases
ECG revealed cardiotropic rhythm without significant slow 
downs, low percentage of stimulation (details: Figure 1). In 
echocardiography, the left ventricle showed regional con-
tractility disorders, lowering of LVEF from 48% to 30%. Du-
ring hospitalization, the condition of the patient remained 
severe. The patient was occasionally agitated, removed 
the PEG — the feeding was continued with the use of a na-
sogastric tube. Decision was made to remove the endoca-
vitary electrode. Pressure ulcers were surgically treated. 
Laryngologist recommended maintaining the endotrache-
al tube due to the necessity of further passive oxygen the-
rapy. Given the severe condition of the patient, treatment 
characteristic of the end of life period had to be conside-
red. The decision was made with the use of the guidelines 
of the Polish Society of Cardiology (PTK, Polskie Towarzy-
stwo Kardiologiczne), according to which the patient met 
most of the criteria suggesting such treatment (Table 2) 
[3]. Due to the overall clinical picture, it was decided that 
the patient would be transferred to a hospice.
(HR) 45/min], blood pressure (BP): 136/58 mm Hg, were 
present. Laboratory tests revealed significantly elevated 
N-terminal pro-B-type natriuretic peptide (NT-proBNP) and 
C-reactive protein (CRP), signs of impaired renal function, 
macrocytic anaemia, hypernateramia, a number of shifts 
in protin fraction panel in the course of inflammation and 
hematuria (detail in Table 1). Electrocardiography (ECG) 
revealed third degree atrioventricular block with escape 
ventricular rhythm 40/min. Echocardiographic signs of HF 
with slightly impaired left ventricular ejection fraction (LVEF) 
were observed: 48%, no sectional contractility disorders 
were observed in the left ventricle and no significant valvu-
lar defects were found. Chest X-ray revelaed inflammatory 
lesions in lower and central lung fields. Blood, sputum, 
urine and rectal swab cultures were performed. The cul-
tures revealed an increase in Klebsiella pneumoniae and 
Pseudomonas aeruginosa. During the hospitalisation the 
patient was unresponsive. A computed tomography (CT) 
scan of the head was performed, revealing foci of vascular 
hypodensity, cortico-subcortical atrophies, without signs 
of cerebral stroke. Due to the fact that patient’s stomach 
was bloated and painful on palpation, an ultrasound of the 
abdominal cavity was performed. It revealed hepatomegaly 
with signs of steatosis, dilated intestinal loops and lack of 
peristalsis. The diagnostics was extended by a CT angio-
graphy of the abdominal cavity that revealed a solid mass 
within the splenic flexure of the transverse colon of 90 mm 
in length and signs of obstruction in the small intestine. 
Gastroscipy revealed a duodenal ulcer covered in fibrin, 
without active bleeding. Colonoscopy did not reveal the 
described mass in the transverse colon.
Salbutamol was administered intravenously in order to 
accelerate the HR. The effect was good. Pneumonia was 
treated with levoflaxcin administered in a standard dose. 
Berodual, budesonide and teophylline were administered 
to achieve bronchodilation. Due to progressing circulatory 
failure and increasing peripheral oedemas, diuretic treat-
ment was intesified. Symptoms of respiratory and renal fa-
ilure were increasing despite the administered treatment, 
the patient was still unresponsive. Decision was made to 
intubate and ventilate the patient; he was temporarily se-
cured with an endocavitary electrode and then transferred 
to the Intensive Care Unit (ICU).
After 2 months of intensive, multidirectional treatment, 
the patient was again transferred to the Cardiology Clinic. 
He was conscious, spontaneously breathing through the 
tracheostomy tube and receiving passive oxygen therapy 
with a flow of 5 L/min, BP 136/80 mm Hg, HR 80/min. Per-
cutaneous endoscope gastrostomy (PEG) was performed 
and the patient was fed with a specialised formula. Auscu-
latory examination revealed symmetric vesicular murmur, 
crackles and rhonchi above the lung fields. Laboratory tests 
revelaed persistent leukocytosis, elevated CRP, macrocytic 
ischemia, normal renal parameters (creatinin: 0.78 mg/dL). 
Table 1. Results of additional examinations during the first hospi-






RBC [× 106/µL] 3.85
HgB [g/dL] 13,2
MCV [fL] 104.2
Na [mmol/L] 163 















NT-proBNP — N-terminal pro-B-type natriuretic peptide; GFR — glomerular filtration rate; RBC — red 
blood count; HgB — hemoglobin; MCV — mean corpuscular volume; Na — sodium; WBC — white 
blood count; CRP — C-reactive protein
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Discussion
There is a number of literature data describing clinical 
assessment and prognosis in HF patients, which are also 
helpful when making the decision regarding the implemen-
tation of palliative treatment. The LVEF value constitutes 
a standard criterion in clinical assessment in HF; in the case 
of patients with LVEF < 45% prognosis is poor and palliative 
treatment should be considered. According to the reports, 
some patients with LVEF > 45% also need such treatment [4]. 
In the described case, due to comorbidities of other systems, 
the condition of the patient who was initially diagnosed with 
HF with slightly impaired LVEF, at the level of 48% (a decrease 
to 30% within 2 months), significantly deteriorated within 
several months and the implementation of treatment cha-
racteristic of the end of life period was necessary. A study 
comparing a group of patients (N = 75) treated with the use 
of traditional pharmacological treatment of HF with a group 
of patients (N = 75) simultaneously treated with heart failure 
and palliative treatment, indicates a significant improvement 
in the comfort of life, reduction in anxiety and the incidence 
of depression as well as improvement in the mental state of 
those patients in whom palliative treatment was additionally 
administered [5]. It confirms the necessity to consider such 
treatment already at early stages of HF advancement, in 
particular when numerous comorbidities are present.
Figure 1. Electrocardiography (ECG) during re-hospitalisation at the Clinic of Cardiology: sinus rhythm frequency 84/min, levogram, left 
His bundle branch block (LBBB), atrioventricular block of the 1st degree, single stimulations from the pacemaker — effective ventricular 
stimulation
Table 2. The guidelines of the Polish Society of Cardiology, helpful when assessing patients with heart failure in whom treatment charac-
teristic of the end of life period should be considered. The criteria met by the described patient are on the darker background (source [3])
Progressive decline in capacity (physical and mental) and lack of independence in most everyday activities
Severe symptoms of heart failure accompanied by low quality of life despite the optimised pharmacotherapy and other management 
methods
Frequent hospotalisations or other serious episodes of decompensation despite optimal treatment
Lack of possibility of heart transplant and mechanical circulatory support
Heart cachexia
Impending end of life in clinical assessment
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monitor the condition of such patients in order not to delay 
the implementation of palliative treatment, which improves 
the quality of life of patients.
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Conclusions
Analysing the above case, it can be concluded that comor-
bidities significantly worsen the prognosis in HF patients 
and may cause adverse course of the disease, despite 
initial diagnosis of HF with slightly impaired LVEF. It prompts 
increased caution and results in a necessity to carefully 
Streszczenie
Niewydolność serca (HF) jest poważnym problemem współczesnej kardiologii ze względu na częstość występowania 
(w Polsce ok. 750 tys.) przy jednoczesnym krótkim czasie przeżycia (tylko ok. 50% pacjentów przeżywa 4 lata od rozpo-
znania). Przedstawiony przypadek kliniczny dotyczy pacjenta z HF obciążonego wieloma chorobami współistniejącymi, 
które znacząco utrudniają określenie rokowania. Ocena kliniczna jest kluczowa w ustaleniu właściwego postępowania 
i podjęciu ewentualnej decyzji o wdrożeniu leczenia paliatywnego. W opisywanym przypadku mimo optymalnej farmako-
terapii HF stan pacjenta w ciągu 2 miesięcy znacząco się pogorszył — do tego stopnia, że trzeba było wdrożyć leczenie 
charakterystyczne dla schyłkowego okresu życia. Takie postępowanie znajduje potwierdzenie w aktualnych doniesie-
niach naukowych sugerujących stosowanie leczenia paliatywnego już na wcześniejszych etapach zaawansowania HF, 
a w szczególności gdy współistnieją ciężkie choroby towarzyszące.
Słowa kluczowe: niewydolność serca, leczenie paliatywne, frakcja wyrzutowa lewej komory, rokowanie
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